Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro

Thrombosis Research

Volumn 78, Issue 2, 1995, Pages 161-171

  Knöfler, Ralf ^a   Nakano, Takamitsu ^b   Nakajima, Katsuyuki ^b   Takada, Yumiko ^a   Takada, Akikazu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

platelet aggregation; PRP; remnant like lipoproteins; whole blood

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; LIPOPROTEIN;

ARTICLE; ASSAY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; CHYLOMICRONS; COLLAGEN; COMPARATIVE STUDY; DIABETES MELLITUS; HUMAN; LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL; LIPOPROTEINS; LIPOPROTEINS, VLDL; PLATELET ACTIVATION; PLATELET AGGREGATION; SUPPORT, NON-U.S. GOV'T;

EID: 0028925992     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00044-5     Document Type: Article

References (33)

1. Platelet activation by plasma lipoproteins
2. Influence of plasma lipoproteins on platelet aggregation in a normal male population
3. Selective release from platelet granules induced by plasma lipoproteins
4. Platelet interaction with high and low density lipoproteins
5. Intracellular mechanisms in the activation of human platelets by lowdensity lipoproteins
6. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules
7. Lipoprotein metabolism and its relationship to atherosclerosis
8. An increase of serum remnant-like particles in noninsulin-dependent diabetic patients with microalbuminuria
9. Increased lipoprotein-remnant formation in chronic renal failure
10. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events
11. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan
12. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study
13. Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia
14. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia
15. Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapy
16. Relationship between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans
17. Atherogenesis: a postprandial phenomenon
18. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels
19. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100
20. THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
21. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay
22. Protein measurement with the Folin phenol reagent
23. The electronic aggregometer: a novel device for assessing platelet behavior in blood
24. Factors influencing platelet aggregation in whole blood
25. Aggregation of blood platelets by adenosine and its reversal
26. Specific binding sites on human blood platelets for plasma lipoproteins
27. Interaction of plasma lipoproteins with human platelets
28. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
29. Inhibition of platelet function by high-density lipoprotein from a patient with apolipoprotein E deficiency
30. The role of apo E in inhibitory effects of apoE-rich-HDL on platelet function
31. Evidence for the presence of red and white cells within “platelet” aggregates formed in whole blood
32. On the inhibitory effect of albumin on platelet aggregation
33. Albumin interferes with arachidonate metabolism in platelets and neutrophils